US Broker Ratings

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Stable Contender in the Healthcare Sector with Modest Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been a reliable name in the healthcare services industry, providing indispensable management and operational services to nursing homes, retirement complexes, rehabilitation centers, and..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unveiling a 197% Potential Upside in the Biotech Sector

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is capturing attention in the healthcare sector with an impressive potential upside of 197.59%. As a pioneering entity in..

NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling a Potential 51.82% Upside for Investors

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, operates at the forefront of cancer diagnostics and research. With a market capitalization of $953.63 million, the company’s innovative..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a 140% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands at an intriguing crossroads in the biotechnology sector, capturing the attention of investors with its promising pipeline targeting rare diseases. As the company ventures..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Evaluating a 24.90% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling opportunity for investors who are keen on the healthcare sector, particularly in the realm of non-opioid pain management. With a market capitalization..

Novavax, Inc. (NVAX) Stock Analysis: A Potential 108.63% Upside in the Biotech Sector

Novavax, Inc. (NASDAQ: NVAX) is a prominent player in the biotechnology industry, operating out of Gaithersburg, Maryland. The company is noted for its innovative approach to vaccine development, particularly its..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Unpacking a 26% Potential Upside with Strong Revenue Growth

For investors eyeing opportunities in the healthcare sector, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling prospect. This biopharmaceutical company, headquartered in Baudette, Minnesota, is making waves with its robust..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 100% Potential Upside in the Biotechnology Arena

MiMedx Group, Inc. (MDXG) is carving a noteworthy niche in the biotechnology sector with its innovative approach to healthcare solutions, specifically through its development and distribution of placental tissue allografts...

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unveiling a 36% Upside Potential for Investors

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its impressive growth prospects. Headquartered in..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a 44.66% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is gaining attention from investors due to its promising developments in cellular metabolism medicines. With a market capitalization..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 63% Upside Potential in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the healthcare sector, particularly within the medical devices industry, with its robust portfolio of diabetes management solutions. Headquartered in San Diego,..

agilon health, inc. (AGL) Stock Analysis: Exploring the 95% Potential Upside

For investors eyeing opportunities in the healthcare sector, agilon health, inc. (NYSE: AGL) presents a compelling case, especially with a potential upside of 95.12% as indicated by current analyst ratings...

Evolent Health, Inc (EVH) Stock Analysis: A Deep Dive into Its 84% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) is an intriguing player in the healthcare sector, specifically within the health information services industry. Headquartered in Arlington, Virginia, the company specializes in providing specialty..

Opko Health, Inc. (OPK) Stock Analysis: A Look at the 200% Potential Upside

Opko Health, Inc. (NASDAQ: OPK), a diversified healthcare company, stands out in the healthcare sector with its dual focus on diagnostics and pharmaceuticals. Headquartered in Miami, Florida, Opko operates across..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 19% Upside Potential

Investors eyeing the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing option, as the company offers a compelling blend of robust growth prospects and a significant potential..

Harrow, Inc. (HROW): Analyst Ratings Signal Strong Buy with 80% Upside Potential

Harrow, Inc. (NASDAQ: HROW), a key player in the ophthalmic pharmaceutical sector, has been gaining traction among investors due to its robust growth potential and promising analyst ratings. Headquartered in..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Compelling 40% Upside Potential for Innovators in Cell Therapy

For investors seeking exposure to the dynamic healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents a fascinating opportunity. With a market capitalization of $1.06 billion, this Bothell, Washington-based company stands..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook on a 22.68% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), headquartered in Atlanta, Georgia, stands as a prominent player in the healthcare sector, focusing on providing diversified home care services across the United States...

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating a 20% Potential Upside for Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook on a Biotech with a 22.85% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) is drawing significant attention from investors, particularly those with an interest in the healthcare sector. This Canadian biotechnology company, with a market capitalization of $1.1..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds